HB Biotechnology https://validator.w3.org/feed/docs/rss2.html News and Insights Gareth Hulbert News and Insights Decoding MFN: Implications (and opportunities) for Biotech Investors Elizabeth McKenzie Daniel Lin Manan Shukla Biotech in FY25: Finding Value, Maintaining Discipline Meet the team CAR-T therapies from Australian Biotechs HB Biotech Unit Trust Quarterly Report June 2026 A Biotech Renaissance Performance Detail Performance Tariffs FDA Cuts and RFK Jnr 2024 Year in Review Time for a Breakout? Biotech Reawakens Fiona Burton Coming home with a wet sail – or just getting warmed up? MnA Gathers Pace Letter from America Sticking to your Guns Global Biotech – a market on sale HB Biotechnology Biotech Boom: Where are the Aussie Investors? Why so many Aussie Biotechs Fail Prostate Cancer Radiotherapeutics Our Philosophy About HB Biotechnology Contact Mar22 Quarterly Review December 2022 Review December 2021 Quarterly Review Charles Williams Why Bio and Medical Technology Thank You – Contact Us Thank you – Charitable Account Stuart Devenish Meares Ronald Kenneth Heinrich Peter Harper Kim Ridge History Rhyming Privacy Stephen Wood Macro has its hand on the tiller (again)